Tiny amounts of air injected subcutaneously are harmless
These findings suggest that IV glutathione may have the potential to slow disease progression and improve symptoms in individuals with various neurological conditions
Knowing your genetic predispositions in GLP-1 and metabolic pathways can support a more informed conversation with your provider about timing, tolerability expectations, and whether compounded semaglutide formulations or dosing protocols might be optimized to manage both your GLP-1 therapy and infection treatment safely
A lot of healthy adults tolerate L-carnitine well
Roche said the Phase II results help build the case for advancing CT-388 into late-stage testing, which is set to get underway this quarter
Sordelli MS, Beltrame JS, Cella M, Franchi AM, Ribeiro ML